Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 100, Issue 5, 2008, Pages 497-505

  Nathan, Robert A ^a   Berger, William ^b   Yang, William ^c   Cheema, Amarjit ^d   Silvey, MaryJane ^e   Wu, Wei ^e   Philpot, Edward ^e  

^a Asthma and Allergy PC and Research Center   (United States)

^b Southern California Research   (United States)

^c Allergy and Asthma Research Centre   (Canada)

^d Alpha Medical Research Inc   (Canada)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE FUROATE; NOSE SPRAY; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPISTASIS; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSAL BLEEDING; MULTICENTER STUDY; NASAL PRURITUS; NOSE CONGESTION; NOSE SEPTUM ULCER; NOSE ULCER; PATIENT COMPLIANCE; PERENNIAL RHINITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECORDING; RHINORRHEA; SCHOOL CHILD; SCORING SYSTEM; SCREENING; SIDE EFFECT; SNEEZING; SORE THROAT; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 43449120682     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60477-2     Document Type: Article

References (25)

1. RM Sly Epidemiology of allergic rhinitis Clin Rev Allergy Immunol 22 2002 67 103
2. J Bousquet P van Cauwenberge N Khaltaev Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 108 2001 S147 S334
3. M Desrosiers P Keith R Schellenberg S Waserman Allergies in Canada: AR patient perspectives on prescription nasal sprays J Allergy Clin Immunol 119 2007 S226
4. RA Settipane P Lieberman Update on nonallergic rhinitis Ann Allergy Asthma Immunol 86 2001 494 507
5. GK Scadding DH Richards MJ Price Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis Clin Otolaryngol Allied Sci 25 2000 551 557
6. A Long C McFadden D DeVine Management of Allergic and Nonallergic Rhinitis Evidence Report/Technology Assessment Number 54 2002 Agency for Healthcare Research and Quality, US Dept of Health and Human Services Rockville, MD
7. University of Michigan Health System Allergic Rhinitis 2002 University of Michigan Health System Ann Arbor
8. Task Force on Allergic Disorders The Allergy Report 1 2000 American Academy of Allergy, Asthma and Immunology Milwaukee, WI
9. MS Dykewicz S Fineman DP Skoner Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology Ann Allergy Asthma Immunol 81 1998 478 518
10. RJ Salib PH Howarth Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis Drug Saf 26 2003 863 893
11. A Valotis P Högger Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate Respir Res 8 2007 54
12. M Salter K Biggadike JL Matthews Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease Am J Physiol Lung Cell Mol Physiol 293 2007 L660 L667
13. A Allen G Down A Newland Absolute bioavailability of intranasal fluticasone furoate in healthy subjects Clin Ther 29 2007 1415 1420
14. BG Martin PH Ratner FC Hampel Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents Allergy Asthma Proc 28 2007 216 225
15. National Asthma Education and Prevention Program Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002 US Dept of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute Bethesda, MD
16. C Lemiere T Bai M Balter Adult asthma consensus guidelines update 2003 Can Respir J 11 suppl A 2004 9A 18A
17. EF Juniper GH Guyatt Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 21 1991 77 83
18. GK Scadding VJ Lund M Holmstrom YC Darby Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis Rhinol Suppl 11 1991 37 43
19. M Andersson R Berglund L Greiff A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis Rhinology 33 1995 18 21
20. J Day T Carrillo Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis J Allergy Clin Immunol 102 1998 902 908
21. MA Stern AG Wade SM Ridout LM Cambell Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine Ann Allergy Asthma Immunol 81 1998 354 358
22. E Kivisaari RC Baker MJ Price Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis Clin Exp Allergy 31 2001 855 863
23. EF Juniper Impact of upper respiratory allergic diseases on quality of life J Allergy Clin Immunol 101 1998 S386 S391
24. HB Kaiser RM Naclerio J Given Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis J Allergy Clin Immunol 119 2007 1430 1437
25. P Ratner C Andrews J Van Bavel Once-daily fluticasone furoate nasal spray (FF) effectively treats ocular symptoms of seasonal allergic rhinitis (SAR) caused by mountain cedar pollen J Allergy Clin Immunol 119 2007 S231